Detalhe da pesquisa
1.
Tumor Response and Symptom Palliation from RAINBOW, a Phase III Trial of Ramucirumab Plus Paclitaxel in Previously Treated Advanced Gastric Cancer.
Oncologist
; 26(3): e414-e424, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33274542
2.
The McCAVE Trial: Vanucizumab plus mFOLFOX-6 Versus Bevacizumab plus mFOLFOX-6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC).
Oncologist
; 25(3): e451-e459, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32162804
3.
Phase II study of the antibody-drug conjugate TAK-264 (MLN0264) in patients with metastatic or recurrent adenocarcinoma of the stomach or gastroesophageal junction expressing guanylyl cyclase C.
Invest New Drugs
; 35(2): 235-241, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28188407
4.
Randomized, double-blind, phase two study of ruxolitinib plus regorafenib in patients with relapsed/refractory metastatic colorectal cancer.
Cancer Med
; 7(11): 5382-5393, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30123970